Pharmaceuticals - Drug Discovery Digest

Going green in pharmaceuticals

Drug Discovery Today

OCTOBER 25, 2023

London, 25/10/2023: The pharmaceutical industry is currently responsible for over four per cent of global carbon emissions and this figure is on track to grow in the coming years. Here Simon Farnfield, event director at Lab Innovations, discusses the changes that are allowing the pharmaceutical industry to go green at last.

Pharmaceuticals

Pharmaceuticals Government

AI-Driven Drug Discovery: Transforming the Landscape of Pharmaceutical Research

Drug Patent Watch

APRIL 16, 2024

The pharmaceutical industry in China is undergoing a significant transformation with the adoption of artificial intelligence (AI) technology. A recent study published in the Future Journal of Pharmaceutical Sciences evaluates… Source

Pharmaceuticals

Pharmaceuticals Research Science Drugs

An AI Approach to Generate Novel Pharmaceuticals using Patent Data

Drug Patent Watch

JANUARY 16, 2024

A recent article published in the Journal of Cheminformatics addresses the challenge of confirming the patent status of newly developed compounds, particularly in the pharmaceutical industry, where generating novel structures… The post An AI Approach to Generate Novel Pharmaceuticals using Patent Data appeared first on DrugPatentWatch - Make Better (..)

Pharmaceuticals

Your Guide to the Ultimate Pharmaceutical Product Improvement Tool

Fierce BioTech

MAY 14, 2024

Your Guide to the Ultimate Pharmaceutical Product Improvement Tool This white paper will review how automating the annual product quality review (APQR) process can help pharmaceutical companies simplify and optimize their product quality review process, to make informed product quality decisions quicker and on a more routine and proactive basis.

Production

Production Pharmaceuticals Pharmaceutical Companies

Legislative Proposals to Tackle Improper Pharmaceutical Patents in the Orange Book

Drug Patent Watch

JANUARY 22, 2024

A recent article published in Health Affairs, delves into the Federal Trade Commission’s (FTC) concerns regarding the inclusion of improper patents in the FDA’s Orange Book by pharmaceutical manufacturers.

Pharmaceuticals

Unveiling the Secrets of Patent Litigation and Settlements in Pharmaceuticals

Drug Patent Watch

JANUARY 8, 2024

The article “Settled: Patent characteristics and litigation outcomes in the pharmaceutical industry,” explores the relationship between Paragraph IV litigation characteristics and the probability of a Paragraph IV settlement in the… The post Unveiling the Secrets of Patent Litigation and Settlements in Pharmaceuticals appeared first on DrugPatentWatch (..)

Pharmaceuticals

Antimicrobial resistance with Recce Pharmaceuticals

Drug Target Review

NOVEMBER 16, 2023

How do Recce Pharmaceuticals’ synthetic anti-infectives differ from current therapies on the market aiming to combat the urgent global health threat posed by antimicrobial resistance (AMR)? About the author James Graham CEO of Recce Pharmaceuticals James Graham is the Chief Executive Officer of Recce Pharmaceuticals.

Pharmaceuticals

Pharmaceuticals Therapies Clinical Trials Trials

The future of technology in pharmaceutical manufacturing

Fierce BioTech

NOVEMBER 6, 2023

In this interview, Charles Chase, PhD, the VP and Technical Business Development at Asymchem, a technology-focused pharmaceutical manufacturing company, discusses the significant impact of RNA vacc | Diversifying manufacturing and investing into emerging technologies improves cost effectiveness, reproducibility, and environmentally friendly processes. (..)

Pharmaceuticals

Pharmaceuticals RNA

Changing the Pharmaceutical Commercialization Landscape

Fierce BioTech

OCTOBER 4, 2023

By Leslie Orne, President and Chief Executive Officer of Trinity Life Sciences | In a dynamic landscape, three emerging trends have the power to reshape the complexities of pharmaceutical commercialization.

Pharmaceuticals

Pharmaceuticals Science

Emerging Technologies for Sustainable Pharmaceutical & Medical Devices Manufacturing

Elrig

APRIL 26, 2024

Emerging Technologies for Sustainable Pharmaceutical & Medical Devices Manufacturing | Insights from Professor Dimitrios Lamprou Professor Dimitrios Lamprou is the Chair of Biofabrication and Advanced Manufacturing at Queen’s University Belfast. He is also the Chair at United Kingdom and Ireland Controlled Release Society (UKICRS).

Pharmaceuticals

Pharmaceuticals Science Doctors Engineering

EU Pharmaceutical Legislation Reform: Where Are We Now?

thought leadership

MARCH 26, 2024

On April 26, 2023, the European Commission proposed a new package of pharmaceutical legislation 1 to revise many of the currently applicable Regulations.

Pharmaceuticals

Pharmaceuticals Packaging Regulations Science

Strategies to Maximize Product Value Amid Loss of Exclusivity in the Pharmaceutical Industry

Drug Patent Watch

AUGUST 21, 2023

In the face of impending patent expirations, pharmaceutical companies can adopt key approaches to preserve meaningful… The post Strategies to Maximize Product Value Amid Loss of Exclusivity in the Pharmaceutical Industry appeared first on DrugPatentWatch - Make Better Decisions.

Production

Production Pharmaceuticals Pharmaceutical Companies Drugs

Cookieless Marketing of Pharmaceuticals Requires Real-World Data

Fierce BioTech

MARCH 19, 2024

Cookieless Marketing of Pharmaceuticals Requires Real-World Data Pharma ads face uncertainty with fading third-party cookies. Adapting to cookieless marketing means integrating real-world data into all campaign phases, demanding close collaboration and reliance on new data sources for effective targeting. Download now.

Marketing

Marketing Pharmaceuticals

The vote is in: The European Parliament has adopted the compromise pharmaceutical legislation

Agency IQ

APRIL 12, 2024

BY KIRSTEN MESSMER, PHD, RAC This week, the European Parliament voted to adopt the compromise texts of both the revised pharmaceutical directive and regulation presented by Parliament’s health committee in March 2024.

Pharmaceuticals

Pharmaceuticals Regulations Research

DrugPatentWatch and Abbvie discuss Pharmaceutical Portfolio Management

Drug Patent Watch

JULY 16, 2021

Come join me and Wendi Lau from Abbvie as we participate in an interactive roundtable discussion on pharmaceutical portfolio management. The post DrugPatentWatch and Abbvie discuss Pharmaceutical Portfolio Management appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceuticals

Sustainability in pharmaceutical manufacturing: a CDMO’s contribution

BioPharma Drive: Drug Pricing

APRIL 29, 2024

Consideration of sustainability early in process development, throughout the entire development cycle, and across the entire supply chain must also become common practice.

Pharmaceuticals

Which pharmaceutical companies have the most drug patents in Hong Kong?

Drug Patent Watch

MAY 5, 2024

This chart shows the pharmaceutical companies with the most patents in Hong Kong. Patents must be filed in each country (or, in some cases regional patent office) where patent protection… Source

Going green in pharmaceuticals

AI-Driven Drug Discovery: Transforming the Landscape of Pharmaceutical Research

Trending Sources

An AI Approach to Generate Novel Pharmaceuticals using Patent Data

Your Guide to the Ultimate Pharmaceutical Product Improvement Tool

Legislative Proposals to Tackle Improper Pharmaceutical Patents in the Orange Book

Unveiling the Secrets of Patent Litigation and Settlements in Pharmaceuticals

Antimicrobial resistance with Recce Pharmaceuticals

The future of technology in pharmaceutical manufacturing

Changing the Pharmaceutical Commercialization Landscape

Emerging Technologies for Sustainable Pharmaceutical & Medical Devices Manufacturing

EU Pharmaceutical Legislation Reform: Where Are We Now?

Strategies to Maximize Product Value Amid Loss of Exclusivity in the Pharmaceutical Industry

Cookieless Marketing of Pharmaceuticals Requires Real-World Data

The vote is in: The European Parliament has adopted the compromise pharmaceutical legislation

DrugPatentWatch and Abbvie discuss Pharmaceutical Portfolio Management

Sustainability in pharmaceutical manufacturing: a CDMO’s contribution

Which pharmaceutical companies have the most drug patents in Hong Kong?

Which pharmaceutical companies have the most SPCs in Netherlands?

Which pharmaceutical companies have the most suppository dosed drugs?

Which pharmaceutical companies have the most drug patents in Serbia?

Which pharmaceutical companies have the most SPCs in France?

Which pharmaceutical companies have the most drug patents in Croatia?

Which pharmaceutical companies have the most SPCs in Lithuania?

Which pharmaceutical companies have the most SPCs in Norway?

Which pharmaceutical companies have the most drug patents in Serbia?

Which pharmaceutical companies have the most drug patents in Philippines?

Which pharmaceutical companies have the most SPCs in Romania?

Which pharmaceutical companies have the most implant dosed drugs?

Which pharmaceutical companies have the most drug patents in Ireland?

Which pharmaceutical drugs have the most drug patents in Ukraine?

Which pharmaceutical companies have the most SPCs in Luxembourg?

Which pharmaceutical companies have the most SPCs in Romania?

Which pharmaceutical drugs have the most drug patents in Finland?

Which pharmaceutical companies have the most aerosol dosed drugs?

Which pharmaceutical drugs have the most drug patents in Finland?

Which pharmaceutical companies have the most drug patents in Croatia?

Which pharmaceutical companies have the most emulsion dosed drugs?

Which pharmaceutical drugs have the most patents?

Which pharmaceutical companies have the greatest global patent coverage?

Which pharmaceutical companies have the most drug patents in Finland?

Which pharmaceutical companies have the most drug patents in Mexico?

Which pharmaceutical companies have the most gas dosed drugs?

Which pharmaceutical companies have the most spray dosed drugs?

Which pharmaceutical companies have the most drug patents in South Korea?

Stay Connected